A Multi-center, Randomized, Double-blind, Placebo Control, Therapeutic Confirmatory, Phase III Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation
Latest Information Update: 07 Dec 2021
At a glance
- Drugs Carvedilol (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Sponsors Chong Kun Dang
Most Recent Events
- 17 May 2019 New trial record